Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Earl

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
BMJ (Clinical Research Ed.)|March 12, 1994
Management of breast cancer. Refer women to multidisciplinary breast clinicsJ R Yarnold, J M Bliss, M Brunt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 12, 2012
Antitumor activity of cell-permeable RUNX3 protein in gastric cancer cellsJunghee Lim, Tam Duong, Nga Do, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2008
Subunit 1 of the prefoldin chaperone complex is required for lymphocyte development and functionShang Cao, Gianluca Carlesso, Anna B Osipovich, et al.
Molecular and Cellular Biology|July 16, 2003
The high-mobility-group box protein SSRP1/T160 is essential for cell viability in day 3.5 mouse embryosShang Cao, Heather Bendall, Geoffrey G Hicks, et al.
Hematological Oncology|December 1, 1996
A phase I trial to assess the value of recombinant human granulocyte colony stimulating factor (R-MeTHuG-CSF, filgrastim) in accelerating the dose rate of chemotherapy for intermediate and high-grade non-Hodgkin's lymphoma (NHL). The Central Lymphoma GroupG M Smith, J A Child, M H Cullen, et al.
Nucleic Acids Research|May 25, 2004
Activation of cryptic 3' splice sites within introns of cellular genes following gene entrapmentAnna B Osipovich, Erica K White-Grindley, Geoffrey G Hicks, et al.
Antibiotics and Chemotherapy|January 1, 1988
Identification of patients at high risk of chemotherapy-induced toxicity in small-cell lung cancerR L Souhami, L Morittu, C M Ash, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1989
Effectiveness of high-dose combination chemotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphomas who are still responsive to conventional-dose therapyJ G Gribben, A H Goldstone, D C Linch, et al.
Molecular & Cellular Proteomics : MCP|February 24, 2007
The diversity of bioactive proteins in Australian snake venomsGeoff W Birrell, Stephen T H Earl, Tristan P Wallis, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 1996
A randomised phase III cross-over study of tamoxifen versus megestrol acetate in advanced and recurrent breast cancerN S Stuart, J Warwick, G R Blackledge, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
BMJ (Clinical Research Ed.)|March 12, 1994
Management of breast cancer. Refer women to multidisciplinary breast clinicsJ R Yarnold, J M Bliss, M Brunt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 12, 2012
Antitumor activity of cell-permeable RUNX3 protein in gastric cancer cellsJunghee Lim, Tam Duong, Nga Do, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2008
Subunit 1 of the prefoldin chaperone complex is required for lymphocyte development and functionShang Cao, Gianluca Carlesso, Anna B Osipovich, et al.
Molecular and Cellular Biology|July 16, 2003
The high-mobility-group box protein SSRP1/T160 is essential for cell viability in day 3.5 mouse embryosShang Cao, Heather Bendall, Geoffrey G Hicks, et al.
Hematological Oncology|December 1, 1996
A phase I trial to assess the value of recombinant human granulocyte colony stimulating factor (R-MeTHuG-CSF, filgrastim) in accelerating the dose rate of chemotherapy for intermediate and high-grade non-Hodgkin's lymphoma (NHL). The Central Lymphoma GroupG M Smith, J A Child, M H Cullen, et al.
Nucleic Acids Research|May 25, 2004
Activation of cryptic 3' splice sites within introns of cellular genes following gene entrapmentAnna B Osipovich, Erica K White-Grindley, Geoffrey G Hicks, et al.
Antibiotics and Chemotherapy|January 1, 1988
Identification of patients at high risk of chemotherapy-induced toxicity in small-cell lung cancerR L Souhami, L Morittu, C M Ash, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1989
Effectiveness of high-dose combination chemotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphomas who are still responsive to conventional-dose therapyJ G Gribben, A H Goldstone, D C Linch, et al.
Molecular & Cellular Proteomics : MCP|February 24, 2007
The diversity of bioactive proteins in Australian snake venomsGeoff W Birrell, Stephen T H Earl, Tristan P Wallis, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 1996
A randomised phase III cross-over study of tamoxifen versus megestrol acetate in advanced and recurrent breast cancerN S Stuart, J Warwick, G R Blackledge, et al.
Pageof 8